Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers (2016)
- Authors:
- USP affiliated authors: LANCHOTE, VERA LUCIA - FCFRP ; COSTA, JOSÉ ABRÃO CARDEAL DA - FMRP ; COELHO, EDUARDO BARBOSA - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.1111/bcp.12917
- Subjects: NEFROPATIAS; FARMACOCINÉTICA; FENÓTIPOS
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2016
- Source:
- Título: British Journal of Clinical Pharmacology
- ISSN: 0306-5251
- Volume/Número/Paginação/Ano: v. 82, n. 1, p. 83-91, 2016
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
NEVES, Daniel V. et al. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers. British Journal of Clinical Pharmacology, v. 82, n. 1, p. 83-91, 2016Tradução . . Disponível em: https://doi.org/10.1111/bcp.12917. Acesso em: 02 abr. 2026. -
APA
Neves, D. V., Lanchote, V. L., Moysés Neto, M., Costa, J. A. C. da, Vieira, C. P., & Coelho, E. B. (2016). Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers. British Journal of Clinical Pharmacology, 82( 1), 83-91. doi:10.1111/bcp.12917 -
NLM
Neves DV, Lanchote VL, Moysés Neto M, Costa JAC da, Vieira CP, Coelho EB. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers [Internet]. British Journal of Clinical Pharmacology. 2016 ; 82( 1): 83-91.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1111/bcp.12917 -
Vancouver
Neves DV, Lanchote VL, Moysés Neto M, Costa JAC da, Vieira CP, Coelho EB. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers [Internet]. British Journal of Clinical Pharmacology. 2016 ; 82( 1): 83-91.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1111/bcp.12917 - Stereoselective analysis of carvedilol in human plasma by lc-ms-ms
- Pharmacokinetics of carvedilol enantiomers in patients with hypertension undergoing continuous ambulatory peritoneal dialysis
- Influence of quinidine, fluvoxamine, and ketoconazole on the enantioseletive pharmacokinetics of citalopram in rats
- Enantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers
- Influence of type-2 diabetes mellitus on the stereoselective kinetic disposition of fluvastatin
- Stereoselective analysis of metoprolol and its metabolites inrat plasma with application to oxidative metabolism
- Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism
- Effect of hypertension on the stereoselective pharmacokinetics of fluvastatin in rats
- Lercanidipine-fluvastatin interaction: pharmacokinetics stereoselectivity in experimental study
- Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
